McKesson (MCK)
(Real Time Quote from BATS)
$508.95 USD
+0.95 (0.19%)
Updated Sep 23, 2024 01:18 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Price, Consensus and EPS Surprise
MCK 508.95 +0.95(0.19%)
Will MCK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MCK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MCK
McKesson (MCK) Stock Moves -0.03%: What You Should Know
4 Stocks to Buy Amid Dental Supplies Industry Challenges
MCK: What are Zacks experts saying now?
Zacks Private Portfolio Services
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
Top Stock Reports for Home Depot, Southern Company & Infosys
Other News for MCK
McKesson Corporation Announces Second Quarter Fiscal 2025 Earnings Release Date
McKesson - Meet The New Dividend Stock On My Watchlist
McKesson price target lowered by $41 at Wells Fargo, here's why
Cardinal Health, Inc. Dividend Stock Analysis
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), McKesson (MCK) and Neurocrine (NBIX)